Charles Schwab Investment Management Inc. Buys 35,035 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Charles Schwab Investment Management Inc. raised its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 3.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,151,654 shares of the medical device company’s stock after purchasing an additional 35,035 shares during the period. Charles Schwab Investment Management Inc. owned 0.58% of Cooper Companies worth $105,872,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Steward Partners Investment Advisory LLC increased its position in shares of Cooper Companies by 19.1% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 1,407 shares of the medical device company’s stock worth $129,000 after acquiring an additional 226 shares in the last quarter. Jones Financial Companies Lllp increased its position in shares of Cooper Companies by 227.7% during the fourth quarter. Jones Financial Companies Lllp now owns 970 shares of the medical device company’s stock worth $89,000 after acquiring an additional 674 shares in the last quarter. Norden Group LLC boosted its holdings in Cooper Companies by 4.7% during the fourth quarter. Norden Group LLC now owns 18,760 shares of the medical device company’s stock worth $1,725,000 after purchasing an additional 838 shares during the last quarter. Smartleaf Asset Management LLC boosted its holdings in Cooper Companies by 55.5% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,264 shares of the medical device company’s stock worth $116,000 after purchasing an additional 451 shares during the last quarter. Finally, Fisher Asset Management LLC boosted its holdings in Cooper Companies by 100.7% during the fourth quarter. Fisher Asset Management LLC now owns 120,868 shares of the medical device company’s stock worth $11,111,000 after purchasing an additional 60,637 shares during the last quarter. 24.39% of the stock is owned by institutional investors.

Cooper Companies Stock Performance

NASDAQ COO opened at $85.00 on Monday. The company’s 50 day moving average is $92.38 and its 200-day moving average is $99.44. The Cooper Companies, Inc. has a 12-month low of $82.61 and a 12-month high of $112.38. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The firm has a market cap of $16.96 billion, a P/E ratio of 43.59, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on COO. Piper Sandler restated an “overweight” rating and set a $115.00 price target (down from $120.00) on shares of Cooper Companies in a report on Friday. JPMorgan Chase & Co. cut their price target on shares of Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a report on Friday. Wells Fargo & Company boosted their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Friday. Finally, Morgan Stanley cut their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. Three equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $111.89.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.